Data supporting a promising, new treatment for Cystic Fibrosis (CF) developed by Verona Pharma will be presented for the first time at the 28th Annual North American Cystic Fibrosis Conference (NACFC) in Atlanta, Georgia on October 9-11, 2014. Verona Pharma’s key molecule, RPL554, is currently being evaluated in a…
News
Dr. Stuart Elborn When it comes to formulating new and improved antibacterial treatments, scientists are in a race against the time it takes for today’s bacteria to mutate into more harmful, resistant strains. Even with today’s technology and advanced research practices, emerging pharmaceutical…
Young adults and children with cystic fibrosis in the United States have better lung function than those who live in the United Kingdom, despite the fact that both countries have well-developed healthcare systems. Differences in lung function may be a result of differences in healthcare structure, according to the…
2014 has been a year highlighted by a steady stream of compelling stories about young people with cystic fibrosis (CF) bearing witness to how a desire to live life to the fullest and lead an active, healthy lifestyle can overcome the daunting challenges and ominous realities of the disease. Joining…
Leerink Partners, a specialty investment bank in the field of healthcare, recently extended an invitation to Insmed Incorporated, the biopharmaceutical company behind a highly promising liposomal amikacin formulation to treat Pseudomonas aeruginosa infections in patients with cystic fibrosis (CF), to participate in a Rare Disease…
One of the pressing concerns physicians have with patients diagnosed with cystic fibrosis (CF) is their increased susceptibility to respiratory infections along with greatly decreased lung clearance. A condition that manifests quite similarly to CF is primary ciliary dyskinesia (PCD), a hereditary condition that impairs lung…
Any concern that may exist over cystic fibrosis patients receiving nasal live-attenuated influenza vaccine (LAIV) due to infection risk may be unfounded, according to a new study conducted by Constantina Boikos, MScPH, from McGill University in Montreal. Dr. Boikos and colleagues evaluated 168 cystic fibrosis patients, ages 2 to…
Josh Brown Tommy Bahama, an island lifestyle brand under Oxford Industries, Inc. that markets casual, sporting, and swimming apparel and footwear, has teamed up with Josh Brown of the New York Giants of the National Football League (NFL) for a cystic fibrosis (CF) fundraising campaign. The…
Melissa Benoit receiving treatment, circa 1983 – Image Credit: The Hospital For Sick Children In the 1980’s, life expectancy for persons with CF was just 12 years in the US, and around 20 in Canada. Melissa Benoit spent the first month of her life in the neonatal…
Drug development companies such as NovaBiotics that are devoted to designing and developing treatments for patients with difficult-to-treat, medically unmet diseases are often faced with the hurdle of recruiting enough patients to conduct the clinical trials necessary to approve new treatments. Recently, the hindrance has…
Your CF Community
Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.